Antibiotic Exposure on Gut Microbiota and Motility Establishment in Newborns

Key facts

Sponsor

The First Hospital of Jilin University

Enrollment

200 target

Eligibility

All sexes

Timeline

2025 – 2027

Study locations (1)

• The first hospital of Jilin university, Changchun, Jilin, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Necrotizing enterocolitis

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNCT07490834
  Long-term Nutritional Impact of Necrotizing Enterocolitis in Premature Newborns.
  Central Hospital, Nancy, France
• RECRUITINGNCT07192393
  Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).
  Imperial College London
• RECRUITINGNANCT06727877
  Predictive Diagnosis of Ulcero-Necrotizing EnteroColitis in Premature Babies Using an Artificial Intelligence Approach Based on Early Analysis of the Fecal Microbiota
  University Hospital, Clermont-Ferrand
• RECRUITINGNCT06681129
  Study of Normal Intestinal Development and Disease in Premature and Term Neonates
  Boston Children's Hospital
• RECRUITINGNCT07152106
  Amniotic Fluid & the Preterm Gut
  Maxima Medical Center
• ACTIVE NOT RECRUITINGNANCT06908239
  Milk Temperature Control and Necrotizing Enterocolitis Risk in Extremely Preterm Infants
  Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
• RECRUITINGNANCT06672913
  Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study
  Baskent University Ankara Hospital
• RECRUITINGPHASE1, PHASE2NCT06315738
  Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis
  Noveome Biotherapeutics, formerly Stemnion

See all trials for Necrotizing enterocolitis →